References
- Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909–920.
- Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695–704.
- Lionakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med 2004; 25: 159–169.
- Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7: 479–504.
- Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10(Suppl. 1): 67–75.
- Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741–754.
- Raad I, Tarrand J, Hanna H, . Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 2002; 23: 532–537.
- Torres HA, Raad II, Kontoyiannis DP. Infections caused by Fusarium species. J Chemother 2003; 15(Suppl. 2): 28–35.
- Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, Mellado E, Rodriguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61: 805–809.
- Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917–921.
- Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother 2009; 53: 2192–2195.
- Guarro J, Pujol I, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother 1999; 43: 1256–1257.
- Cornely OA. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 2008; 36: 296–313.
- Mayayo E, Pujol I, Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol 1999; 48: 363–366.
- Azor M, Gene J, Cano J, Guarro J. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 2007; 51: 1500–1503.
- Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic performance of the (1– > 3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49: 1650–1659.
- Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1– > 3)-beta-D-glucan assay for the diagnosis of invasive fungal infections – a study based on autopsy cases from 6 years. Clin Infect Dis 2008; 46: 1864–1870.
- Buitrago MJ, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL, Cuenca-Estrella M. Detection of Aspergillus spp. real time in a mouse model of lung infection. Enferm Infecc Microbiol Clin 2005; 23: 464–468.
- Tang CM, Cohen J, Holden DW. An Aspergillus fumigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol Microbiol 1992; 6: 1663–1671.
- Sambrook JE, Fritsch F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd NY: Cold Spring Harbor Laboratory Press; 1989.
- Castelli MV, Buitrago MJ, Bernal-Martinez L, . Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J Clin Microbiol 2008; 46: 3412–3416.
- Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247–5254.
- O'Donnell K, Sutton DA, Rinaldi MG, . Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol 2004; 42: 5109–5120.
- O'Donnell K, Sutton DA, Rinaldi MG, . Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48: 3708–3718.
- Skovgaard K, Rosendahl S, O'Donnell K, Nirenberg HI. Fusarium commune is a new species identified by morphological and molecular phylogenetic data.Mycologia 2003; 95: 630–636.
- Balajee SA, Borman AM, Brandt ME, . Sequence-based identification of Aspergillus, Fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47: 877–884.
- Hue FX, Huerre M, Rouffault MA, de Bievre C. Specific detection of Fusarium species in blood and tissues by a PCR technique. J Clin Microbiol 1999; 37: 2434–2438.
- Ahmad S, Khan ZU, Theyyathel AM. Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model. Mycoses 2010; 53: 40–47.
- Lau A, Sorrell TC, Chen S, . Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 2008; 46: 3021–3027.
- Spiess B, Seifarth W, Hummel M, . DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 3743–3753.
- Campa D, Tavanti A, Gemignani F, . DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J Clin Microbiol 2008; 46: 909–915.
- Jaeger EE, Carroll NM, Choudhury S, . Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin Microbiol 2000; 38: 2902–2908.